Photo: Facebook/Teva Magyarországon
The Israeli-owned Teva Group handed over a new plant in Debrecen. The investment worth almost USD 23 million serves to increase capacity.
Teva’s commitment to safe patient care is demonstrated by this project, which currently represents one of Teva’s largest and most important investments in active ingredient production worldwide and is also the largest development of the Debrecen site in active ingredient production in the world last 15 years.
Teva is the world’s largest manufacturer and supplier of generic medicines, providing medicines to around 200 million patients.